121 related articles for article (PubMed ID: 8622082)
1. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients.
Stephens AW; Gonin R; Hutchins GD; Einhorn LH
J Clin Oncol; 1996 May; 14(5):1637-41. PubMed ID: 8622082
[TBL] [Abstract][Full Text] [Related]
2. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
[TBL] [Abstract][Full Text] [Related]
3. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling.
Sugawara Y; Zasadny KR; Grossman HB; Francis IR; Clarke MF; Wahl RL
Radiology; 1999 Apr; 211(1):249-56. PubMed ID: 10189480
[TBL] [Abstract][Full Text] [Related]
4. The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
Spermon JR; De Geus-Oei LF; Kiemeney LA; Witjes JA; Oyen WJ
BJU Int; 2002 Apr; 89(6):549-56. PubMed ID: 11942962
[TBL] [Abstract][Full Text] [Related]
5. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
Hain SF; O'Doherty MJ; Timothy AR; Leslie MD; Harper PG; Huddart RA
Br J Cancer; 2000 Oct; 83(7):863-9. PubMed ID: 10970686
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy.
Johns Putra L; Lawrentschuk N; Ballok Z; Hannah A; Poon A; Tauro A; Davis ID; Hicks RJ; Bolton DM; Scott AM
Urology; 2004 Dec; 64(6):1202-7. PubMed ID: 15596197
[TBL] [Abstract][Full Text] [Related]
8. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
[TBL] [Abstract][Full Text] [Related]
9. Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum.
Vuky J; Bains M; Bacik J; Higgins G; Bajorin DF; Mazumdar M; Bosl GJ; Motzer RJ
J Clin Oncol; 2001 Feb; 19(3):682-8. PubMed ID: 11157018
[TBL] [Abstract][Full Text] [Related]
10. Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors.
Hartmann JT; Rick O; Oechsle K; Kuczyk M; Gauler T; Schöffski P; Schleicher J; Mayer F; Teichmann R; Kanz L; Bokemeyer C
Ann Surg; 2005 Aug; 242(2):260-6. PubMed ID: 16041217
[TBL] [Abstract][Full Text] [Related]
11. The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies.
Sheinfeld J
Semin Urol Oncol; 2002 Nov; 20(4):262-71. PubMed ID: 12489059
[TBL] [Abstract][Full Text] [Related]
12. Imaging of intrathoracic metastases of nonseminomatous germ cell tumors.
Meyer CA; Conces DJ
Chest Surg Clin N Am; 2002 Nov; 12(4):717-38. PubMed ID: 12471874
[TBL] [Abstract][Full Text] [Related]
13. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
[TBL] [Abstract][Full Text] [Related]
14. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
[TBL] [Abstract][Full Text] [Related]
15. Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology.
Stomper PC; Jochelson MS; Garnick MB; Richie JP
AJR Am J Roentgenol; 1985 Oct; 145(4):743-6. PubMed ID: 3875994
[TBL] [Abstract][Full Text] [Related]
16. Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow up.
Karapetis CS; Strickland AH; Yip D; Steer C; Harper PG
Intern Med J; 2003; 33(9-10):427-35. PubMed ID: 14511195
[TBL] [Abstract][Full Text] [Related]
17. Primary mediastinal nonseminomatous germ cell tumors: the influence of postchemotherapy pathology on long-term survival after surgery.
Kesler KA; Rieger KM; Ganjoo KN; Sharma M; Fineberg NS; Einhorn LH; Brown JW
J Thorac Cardiovasc Surg; 1999 Oct; 118(4):692-700. PubMed ID: 10504636
[TBL] [Abstract][Full Text] [Related]
18. Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.
De Santis M; Bokemeyer C; Becherer A; Stoiber F; Oechsle K; Kletter K; Dohmen BM; Dittrich C; Pont J
J Clin Oncol; 2001 Sep; 19(17):3740-4. PubMed ID: 11533096
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse.
Sanchez D; Zudaire JJ; Fernandez JM; Lopez J; Arocena J; Sanz G; Gimenez M; Rosell D; Robles JE; Berian JM
BJU Int; 2002 Jun; 89(9):912-6. PubMed ID: 12010239
[TBL] [Abstract][Full Text] [Related]
20. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]